Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view).
Medtronic (MDT) is trading at $88.96, down 0.38% on the day. Its market value of $113.79B makes it the 136th largest of the 300 companies we follow.
Over the past 52 weeks it has traded between $72.65 and $103.76, so it sits 14.3% below the top of that range. Holders are behind 4.1% over twelve months, but up 12.0% across the last three months.
Price is below the 50-day average ($89.23) but above the 200-day ($88.20); RSI is 48, and the last 30 sessions moved at roughly 20% annualized volatility.
Revenue for the quarter ended Jul 2026 was $9.76B, up 13.7% from a year earlier, with $1.48B of net profit (a 13.9% margin).
Valuation works out to 21.9 times trailing earnings, 20% below its five-year average of 27.2. The median for its industry group is 23.8.
19 analysts follow the stock and the average call is "buy". The mean target, $104.13, sits 17.1% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Medtronic makes pacemakers, insulin pumps, spinal implants and surgical tools, and is spinning off its diabetes unit.
What tends to move it. Growth in its cardiac ablation devices and the diabetes separation are the things to watch.
Written by hand by the BeStock desk and revised when a business changes. See how we work. Spot something out of date? Tell us.
Price return over each window, from adjusted daily and weekly closes
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | -3.3% | Bearish |
| Price vs 50-day average | -0.3% | Bearish |
| Price vs 200-day average | +0.9% | Bullish |
| 50-day vs 200-day | 50d above 200d | Bullish |
| RSI (14) | 47.8 | Bearish |
| MACD (12,26,9) | 0.55 | Bearish |
| Bollinger band position | -18% | Neutral |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
Quote as of Sep 24, 2026 1:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 300 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A row is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Latest reported quarter: Q1, ended Jul 2026
Quarter 2027/Q1
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 10th percentile, 5-year average 27.2x
#1756 of 2974 stocks by PE (1 = cheapest)
Above its usual level · 63rd percentile, 5-year average 2.3x
#3193 of 5300 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 13th percentile, 5-year average 3.6x
#3135 of 5139 stocks by PS (1 = cheapest)
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Who holds it, who is betting against it, and where the big money is moving
Net of large-order buying minus selling, in USD. Over this window: −$109.60M (7 inflow days, 13 outflow days).
Across the full calendar years shown, the annual payout grew by roughly 5.4% a year.
$88.96 is the latest print for MDT, a move of -0.38% against yesterday's close of $89.30. Today's low and high so far: $88.88 and $90.28.
Equity value comes to $113.79B at the current price. By that measure it is number 136 of the 300 names in our coverage.
Buyers pay 21.9 times the last twelve months of profit (EPS $3.73). Averaged over five years the multiple has been 27.2, and today's level ranks in the 10th percentile of its own history.
The year's floor is $72.65 and the ceiling $103.76. Shares are 14.3% away from that ceiling.
It does. Payouts over the past twelve months work out to a 3.20% yield; the latest ex-dividend date was June 26, 2026.
Of 19 analysts, 63% say buy, 37% hold and 0% sell. Price targets average $104.13, with the most cautious at $85.00 and the most optimistic at $118.00.
Medtronic makes pacemakers, insulin pumps, spinal implants and surgical tools, and is spinning off its diabetes unit.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.